Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Risk Stratification for Intermediate- and High-Risk Patients

被引：3
|
作者：
Katz, A. [1 ]
Kang, J. [2 ]
机构：
[1] FROS Radiat Oncol & CyberKnife Ctr, Flushing, NY USA
[2] Cornell Univ, Coll Med, New York, NY 10021 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.1251
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2608
引用
收藏
页码：E250 / E250
页数：1
相关论文
共 50 条
  • [41] Value of PHI and PHID in the detection of intermediate- and high-risk prostate cancer
    Filella, Xavier
    Foj, Laura
    Wijngaard, Robin
    Luque, Pilar
    [J]. CLINICA CHIMICA ACTA, 2022, 531 : 277 - 282
  • [42] Stereotactic Body Radiotherapy for Localized Low-Intermediate Risk Prostate Cancer
    Haas, J.
    Santoro, M.
    Ashley, R.
    Mucciolo, R.
    Andrews, J.
    Clancey, O.
    Episcopia, K.
    Accordino, D.
    Sanchez, A.
    Witten, M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S432 - S432
  • [43] Dose escalation with HDR brachytherapy for intermediate- and high-risk prostate cancer
    Chicas-Sett, R.
    Celada, F.
    Burgos, J.
    Farga, D.
    Perez-Calatayud, M.
    Roldan, S.
    Collado, E.
    Ibanez, B.
    Perez-Calatayud, J.
    Tormo, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S380 - S381
  • [44] Robotic Extended Pelvic Lymphadenectomy for Intermediate- and High-Risk Prostate Cancer
    Yuh, Bertram E.
    Ruel, Nora H.
    Mejia, Rosa
    Wilson, Chelsea M.
    Wilson, Timothy G.
    [J]. EUROPEAN UROLOGY, 2012, 61 (05) : 1004 - 1010
  • [45] A Phase 1 study Combining Pexidartinib, Radiation Therapy, and Androgen Deprivation Therapy in Men With Intermediate- and High-Risk Prostate Cancer
    Hamid, Muhammad
    Heilbrun, Lance K.
    Maier, Jordan
    Devisetty, Kiran
    Connolly, Irene
    Kaufman, Isaac
    Dobson, Kimberlee
    Herroon, Mackenzie K.
    Smith, Daryn
    Sampson, Sandra
    Podgorski, Izabela
    Heath, Elisabeth I.
    [J]. ADVANCES IN RADIATION ONCOLOGY, 2021, 6 (04)
  • [46] Hypofractionated versus conventional radiotherapy in intermediate- to high-risk prostate cancer
    Guo, W.
    Gao, X. S.
    Gu, X. B.
    Ma, M. W.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S716 - S716
  • [47] Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991
    Bolla, Michel
    Maingon, Philippe
    Carrie, Christian
    Villa, Salvador
    Kitsios, Petros
    Poortmans, Philip M. P.
    Sundar, Santhanam
    van der Steen-Banasik, Elzbieta M.
    Armstrong, John
    Bosset, Jean-Francois
    Herrera, Fernanda G.
    Pieters, Bradley
    Slot, Annerie
    Bahl, Amit
    Ben-Yosef, Rahamim
    Boehmer, Dirk
    Scrase, Christopher
    Renard, Laurette
    Shash, Emad
    Coens, Corneel
    van den Bergh, Alphonsus C. M.
    Collette, Laurence
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15) : 1748 - +
  • [48] Stereotactic Body Radiation Therapy for Localized Prostate Cancer
    Lischalk, Jonathan W.
    Kaplan, Irving D.
    Collins, Sean P.
    [J]. CANCER JOURNAL, 2016, 22 (04): : 307 - 313
  • [49] Randomized Phase 3 Trial of Adjuvant Androgen Deprivation in Combination With High-Dose Conformal Radiation Therapy in Intermediate- and High-Risk Localized Prostate Cancer
    Zapatero, A.
    Guerrero, A.
    Maldonado, J.
    Alvarez, A.
    Gonzalez San Segundo, C.
    Cabeza Rodriguez, M.
    Macias, V.
    Pedro-Olive, A.
    Casas, F.
    Boladeras, A.
    Martin de Vidales, C.
    Vazquez de la Torre, M.
    Calvo, F. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S1 - S1
  • [50] Brachytherapy Increased use in patients with intermediate- and high-risk prostate cancers
    Ali, Sanna
    Esper, Peg
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2021, 25 (03) : 321 - 328
12345